Skip to content

Effect of a Mobile Health Intervention on Treatment Adherence

Effect of an Mobile Health Intervention on Adherence to Antiretroviral Treatment in Adult Patients Living With HIV Compared to Standard Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05187741
Enrollment
80
Registered
2022-01-12
Start date
2022-04-01
Completion date
2022-11-15
Last updated
2022-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV I Infection

Keywords

electronic health, adherence

Brief summary

This is a randomized clinical trial across the whole of the patients who attend the HIV Unit of the Hospital Civil Viejo, a sample calculated in 43 patients for each group (intervention and control). Patients who have HIV infection and are starting antiretroviral treatment (ART), who are between 18 and 50 years old and have a mobile device, will be included in the study. The messages will consist of medical appointment reminders and adherence and motivational messages for a period of six months.

Interventions

A message will be sent on Monday and Friday at 9:00 am for 3 months, the first day they will receive a message focused on adherence and the second day a message focused on motivation. Subsequently, a message will be sent on Mondays for 3 more months. Reminders for appointments with your treating physician will be sent during the entire intervention period (6 months).

Sponsors

Hospital Civil de Guadalajara
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recently diagnosed with HIV infection . starting with antiretroviral therapy and haven't taken ART before * Patients with the status of lost to follow up who return to re-initiate ART

Exclusion criteria

* Patients who are participating in other study * patients above 18 years old * Patients who does not have signal phone at their residency * Those who refuses to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
antiretroviral treatment adherence6 monthsThe practice of patients where they take their medications as prescribed. To proceed with the calculation, the following formula should be applied: \[(number of units dispensed - number of units remaining) / (prescribed number of units per day x number of days between the two visits)\] x 100.

Secondary

MeasureTime frameDescription
care retention6 monthsPerson living with HIV who enters and remains in comprehensive HIV care by health services, according to their needs. It is recorded at 6 months and 12 months of follow-up, with the patient's compliance with their medical appointments.
HIV viral loal6 monthsAmount of genetic material (RNA) of the virus in blood in the most recent determination.Measure by Reverse transcriptase polymerase chain reaction test reported as copies/ml
TCD4+ count in blood6 monthsNumber of CD4 + T lymphocytes in the blood. Measure by flow cytometry and reported as cells/mm3

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026